Evidence map›Paper›PMID 36847392›Full record

ArticleACS nano2023

Personalized Oncology by In Vivo Chemical Imaging: Photoacoustic Mapping of Tumor Oxygen Predicts Radiotherapy Efficacy.

Janggun Jo, Jeff Folz, Maria E Gonzalez, Alessandro Paolì, Ahmad Eido, Eamon Salfi, Shilpa Tekula, Sebastiano Andò, Roberta Caruso, Celina G Kleer and 2 more

Open access · greenAbstract read
In one paragraph

Article in ACS nano, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 21 citations in OpenAlex.

  1. Early Radiation Therapy Response Assessment Using Multi-Scale Photoacoustic Imaging.Advanced science (Weinheim, Baden-Wurttemberg, Germany) · 2026
    Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 4 institutions in 2 countries.

Janggun JoDepartment of Biomedical Engineering, University of Michigan, Ann Arbor, Michigan 48109, United States.ORCID 0000-0001-8131-7197
Jeff FolzDepartment of Chemistry, University of Michigan, Ann Arbor, Michigan 48109, United States.ORCID 0000-0002-4823-3343
Maria E GonzalezDepartment of Pathology and Rogel Cancer Center, University of Michigan Health System, Ann Arbor, Michigan 48109, United States.ORCID 0000-0002-3793-0397
Alessandro PaolìDepartment of Pathology and Rogel Cancer Center, University of Michigan Health System, Ann Arbor, Michigan 48109, United States.ORCID 0000-0003-2014-9147
Ahmad EidoDepartment of Pathology and Rogel Cancer Center, University of Michigan Health System, Ann Arbor, Michigan 48109, United States.ORCID 0000-0001-9530-2519
Eamon SalfiDepartment of Biomedical Engineering, University of Michigan, Ann Arbor, Michigan 48109, United States.ORCID 0000-0002-3393-2475
Shilpa TekulaDepartment of Pathology and Rogel Cancer Center, University of Michigan Health System, Ann Arbor, Michigan 48109, United States.ORCID 0000-0002-5086-4953
Sebastiano AndòDepartment of Pharmacy, Health and Nutritional Sciences, University of Calabria, Rende (CS) 87036, Italy.ORCID 0000-0002-5412-7045
Roberta CarusoDepartment of Pathology and Rogel Cancer Center, University of Michigan Health System, Ann Arbor, Michigan 48109, United States.ORCID 0000-0002-9891-0082
Celina G KleerDepartment of Pathology and Rogel Cancer Center, University of Michigan Health System, Ann Arbor, Michigan 48109, United States.ORCID 0000-0001-8195-185X
Xueding WangDepartment of Biomedical Engineering, University of Michigan, Ann Arbor, Michigan 48109, United States.ORCID 0000-0002-2974-6258
Raoul KopelmanDepartment of Chemistry, University of Michigan, Ann Arbor, Michigan 48109, United States.ORCID 0000-0002-7770-8272
Michigan Medicine · USUniversity of Michigan · USUniversity of Calabria · ITUniversity of Padua · IT

Funding

Role of EZH2 in Breast Cancer ProgressionR01CA107469 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Celina G Kleer · 2005 to 2026
$5.9M
Role of CCN6 (WISP3) in the Progression and Metastasis of Breast Cancer.R01CA125577 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI Celina G Kleer · 2008 to 2026
$5.5M
Personalized Cancer Therapy Guided by Photoacoustic Chemical Imaging (PACI) of Tumor Microenvironment (TME)R01CA250499 · NCI · UNIVERSITY OF MICHIGAN AT ANN ARBOR · PI KLEER, CELINA G, WANG, XUEDING · 2020 to 2025
$3.1M
NCI NIH HHS R01 CA107469NCI NIH HHS R01 CA125577NCI NIH HHS R01 CA250499
6 · The paper itself

Abstract

We hereby apply the approach of photoacoustic chemical imaging, performing an in vivo chemical analysis that is spatially resolved (200 μm) and in real time, to predict a given tumor's response to therapy. Using triple negative breast cancer as a model, we took photoacoustic images of tumors' oxygen distributions in patient-derived xenografts (PDXs) in mice using biocompatible, oxygen-sensitive tumor-targeted chemical contrast nanoelements (nanosonophores), which function as contrast agents for photoacoustic imaging. Following radiation therapy, we established a quantitatively significant correlation between the spatial distribution of the initial oxygen levels in the tumor and its spatial distribution of the therapy's efficacy: the lower the local oxygen, the lower the local radiation therapy efficacy. We thus provide a simple, noninvasive, and inexpensive method to both predict the efficacy of radiation therapy for a given tumor and identify treatment-resistant regions within the tumor's microenvironment.

Indexed as

NanoparticlesNeoplasmsPhotoacoustic TechniquesAnimalsCell Line, TumorHumansMiceOxygenTumor MicroenvironmentOxygenbreast cancer oxygen imagingnanoparticlesphotoacousticradiotherapyTME (tumor microenvironment)TTCCNE (tumor targeted chemical contrast nanoelements)

Identifiers

PMID36847392
PMCPMC10149113
OpenAlexW4322494942

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.